Table of Contents Table of Contents
Previous Page  68 / 88 Next Page
Information
Show Menu
Previous Page 68 / 88 Next Page
Page Background

68

Scientific Programme /

Thursday, 22 June 2017

WFSBP 2017

THU

P-21

POSTER TOUR

13:00–14:30

Congress Hall A 1

Schizophrenia 3

Chair:

Janusz Rybakowski, Poland

001

Variability of 128 schizophrenia-associated gene

variants across distinct ethnic populations

Kazutaka Ohi, Japan

T. Shimada, T. Yasuyama, T. Uehara, Y. Kawasaki

002

Association study between Dysbindin gene and

schizophrenia in a Korean population

Kyu-Young Lee, Germany

E.-J. Joo

003

Low methylation rates of dopamine receptor D2

gene promoter sites in Japanese schizophrenia subjects

Yuta Yoshino, Japan

K. Kawabe, Y. Mori, K. Yamazaki, J.-I. Iga, S.-I. Ueno

005

Gender-specific associations of the brain-derived

neurotrophic factor Val66Met polymorphism with neu-

rocognitive and clinical features in schizophrenia

Sung-Wan Kim, Republic of Korea

Y.-H. Lee, T.-Y. Yoo, J.-Y. Lee, J.-M. Kim, I.-S. Shin, J.-S. Yoon

006

Sequencing of neurotrophic tyrosine receptor

kinase 1 gene region in Armenian schizophrenia patients

Roksana Zakharyan, Armenia

A. Arakelyan

007

Clinical characteristics of formal thought disorder

in schizophrenia

Ho-Seon Lee, Republic of Korea

S.-C. Park

009

SorCS1 regulates inhibitory networks and gamma-

oscillations – a link to schizophrenia?

Peter Lund Ovesen, Denmark

U. Bølcho, K. M. Pedersen, S. Mølgaard Jensen, S. Glerup,

M. M. Holm, A. Nykjær

010

Impact of familial loading on prefrontal activation

in major psychiatric disorders: A Near-Infrared

Spectroscopy (NIRS) study

Kazutaka Ohi, Japan

T. Shimada, H. Kihara, T. Yasuyama, K. Sawai, K. Oshima,

H. Okubo, Y. Nitta, T. Uehara, Y. Kawasaki

011

Total and high-affinity-state dopamine D2 recep-

tors in the striatum of antipsychotic-free patients with

schizophrenia: A PET study with [11C] raclopride and

[11C] MNPA

Manabu Kubota, Japan

T. Nagashima, H. Takano, F. Kodaka, H. Fujiwara,

K. Takahata, S. Moriguchi, Y. Kimura, M. Higuchi,

Y. Okubo, H. Takahashi, T. Suhara

013

Brain anatomy of symptom stratification in schizo-

phrenia: A voxel based morphometry study

Giuseppe Delvecchio, Italy

A. Lorandi, C. Perlini, M. Barillari, M. Ruggeri,

A. C. Altamura, M. Bellani, P. Brambilla

014

White matter correlates of impaired gesture per-

formance and recognition in schizophrenia

Petra Viher, Switzerland

P. Savadjiev, K. Stegmayer, N. Makris, S. Karmacharya,

A. Federspiel, S. Bohlhalter, T. Vanbellingen, R. Wiest,

M. E. Shenton, W. K. Strik, M. Kubicki, S. Walther

015

Is the perception of language cues different in

schizophrenia?: A pilot study

Marie Bendova, Czech Republic

Y. Zaytseva, M. Kolarova, M. Mojzisek, J. Rydlo, R. Gaspar,

F. Spaniel

016

Amelioration of abnormal beliefs in subjects at

ultra high-risk for psychosis linked to longitudinal in-

crease in ventral striatal function during salience

processing

André Schmidt, Switzerland

M. Antoniades, P. Allen, A. Egerton, C. Chaddock,

S. Borgwardt, P. Fusar-Poli, J. Roiser, O. Howes,

P. McGuire

017

The N-Methyl D-Aspartate glutamate receptor

antagonist ketamine disrupts the functional state of

the corticothalamic pathway

Paul Anderson, The Netherlands

N. Jones, T. O'Brien, D. Pinault

018

Impact of trauma on negative symptoms of schizo-

phrenia

Ombline Bolloré, France

D. Fouques, C. Isaac, D. Januel

020

Formal thought disorder in schizophrenia patients:

Gender differences

Joon-Ho Choi, Republic of Korea

J.-E. Park, S.-C. Park

021

The validity and sensitivity of PANSS-6 in the Clini-

cal Antipsychotic Trials of Intervention Effectiveness

(CATIE) study

Søren Dinesen Østergaard, Denmark

L. Foldager, O. Mors, P. Bech, C. U. Correll

022

Novel strategies of treatment of mental disorders

based on D-cell hypothesis

Keiko Ikemoto, Japan